CD8A and granulomatosis with polyangiitis: While not specifically focused on the autoreactive B cells themselves, it has been demonstrated in GPA patients that rituximab lowered the frequency of circulating CD8+ TEMRA cells, whereas the frequencies of different CD4+ T cell subsets and Treg cells were unaffected.